The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Turner Heather D since 2012.
The trader's CIK number is 1403571.
At the time of the last reporting, Turner Heather D was the SVP, Gen. Counsel & Secretary of Atara Biotherapeutics, Inc.. (stock ticker symbol ATRA).
Also see all insider trading activities at Atara Biotherapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | OREX | 0 | $0 | 354,031 | $1,658,236 | 354,031 | $587,690 |
2012 | OREX | 0 | $0 | 82,433 | $633,415 | 82,433 | $136,838 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | ATRA | 0 | $0 | 12,214 | $477,591 | 0 | $0 |
2017 | ATRA | 0 | $0 | 12,215 | $194,584 | 0 | $0 |
1. Orexigen Therapeutics, Inc. (OREX)
2. Atara Biotherapeutics, Inc. (ATRA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-12-02 | OREX | Option Ex | 22,643 | 1.66 | 37,587 |
2014-12-02 | OREX | Sale | 22,643 | 6.00 | 135,858 |
2014-11-24 | OREX | Option Ex | 24,006 | 1.66 | 39,849 |
2014-11-25 | OREX | Option Ex | 7,382 | 1.66 | 12,254 |
2014-11-24 | OREX | Sale | 24,006 | 5.77 | 138,586 |
2014-11-25 | OREX | Sale | 7,382 | 6.00 | 44,292 |
2014-09-22 | OREX | Option Ex | 300,000 | 1.66 | 498,000 |
2014-09-22 | OREX | Sale | 300,000 | 4.46 | 1,339,500 |
2012-07-17 | OREX | Option Ex | 82,433 | 1.66 | 136,838 |
2012-07-17 | OREX | Sale | 82,433 | 7.68 | 633,415 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-02-09 | ATRA | Sale | 12,214 | 39.10 | 477,591 |
2017-02-09 | ATRA | Sale | 12,215 | 15.93 | 194,584 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turner Heather D (SVP, Gen. Counsel & Secretary of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.